Management of Pathological Jaundice

Immediate Actions

The American Academy of Pediatrics recommends initiating intensive phototherapy immediately using special blue light with irradiance ≥30 μW/cm²/nm positioned as close as safely possible to the infant, and preparing for possible exchange transfusion if the bilirubin continues to rise or approaches 25 mg/dL (428 μmol/L) 1
Obtain total serum bilirubin and direct/conjugated bilirubin, blood type and Coombs test, complete blood count with differential, reticulocyte count, serum albumin, and G6PD if ethnically indicated 1, 2

Expect bilirubin decline of at least 0.5-1 mg/dL per hour in the first 4-8 hours with effective intensive phototherapy 1
Continue monitoring every 4-6 hours until bilirubin shows consistent downward trend 1

Prepare for immediate exchange transfusion if TSB ≥25 mg/dL (428 μmol/L) despite intensive phototherapy, or if any signs of intermediate to advanced acute bilirubin encephalopathy are present, regardless of bilirubin level 1, 2

Bilirubin rise ≥0.3 mg/dL per hour in first 24 hours or ≥0.2 mg/dL per hour thereafter suggests hemolysis 3

Discontinue phototherapy when TSB falls to 13-14 mg/dL (222-239 μmol/L) or 2-4 mg/dL below the threshold at which phototherapy was initiated 1, 3

Never rely on visual assessment alone—always obtain objective TSB or transcutaneous bilirubin measurement 2, 3
Do not subtract direct bilirubin from total bilirubin when making treatment decisions 1, 3

Educate parents about warning signs requiring immediate medical attention: poor feeding, extreme lethargy, high-pitched crying, arching of back or neck, fever, or any change in muscle tone 1, 3
Reassure parents that with appropriate treatment, the vast majority of cases resolve without neurological sequelae 4, 5